4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) has 149 institutional investors with active 13F positions as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 195,746 | 5.06% | $0.00 |
| RA CAPITAL MANAGEMENT, L.P. | 31 Dec, 2025 | 0 | 1,090,000 | 23.89% | $0.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 0 | 1,539,860 | 0.00% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -38,037 | -18.23% | $0.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 0 | 2,882,508 | 164.40% | $0.00 |
| Evergreen Quality Fund GP, Ltd. | 31 Dec, 2025 | 0 | 951,474 | 0.00% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 35,983 | 28,786.40% | $0.00 |
| BVF INC/IL | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Burkehill Global Management, LP | 31 Dec, 2025 | 0 | 275,000 | 0.00% | $0.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 0 | 174,489 | 4.23% | $0.00 |
| Peapod Lane Capital LLC | 31 Dec, 2025 | 0 | -54,057 | -16.78% | $0.00 |
| Novo Holdings A/S | 31 Dec, 2025 | 0 | 1,650,737 | 82.54% | $0.00 |
| ADAR1 Capital Management, LLC | 31 Dec, 2025 | 0 | 216,712 | 1,296.74% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 518,405 | 20.13% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | 136,392 | 143.72% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 1,785,106 | 197.52% | $0.00 |
| Privium Fund Management B.V. | 31 Dec, 2025 | 0 | 12,542 | 6.35% | $0.00 |
| ARMISTICE CAPITAL, LLC | 31 Dec, 2025 | 0 | 840,000 | 76.64% | $0.00 |
| Woodline Partners LP | 31 Dec, 2025 | 0 | 200,001 | 0.00% | $0.00 |
| Federated Hermes, Inc. | 31 Dec, 2025 | 0 | 14,650 | 0.92% | $0.00 |